Lycopene induces insulin signaling and alleviates fibrosis in experimental model of non-alcoholic fatty liver disease in rats
Authors:
- Noha M. SaeedNSNoha M. Saeed
- Ahmed M. MansourAMAhmed M. Mansour
- Shady AllamSAShady Allam
- 1 December 2020
- journal article
- research article
- Published by Elsevier in PharmaNutrition
- Vol. 14
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)International Journal of Molecular Sciences, 2013
- Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In VitroPLOS ONE, 2012
- JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery diseaseWorld Journal of Gastroenterology, 2011
- Macrophages: Master Regulators of Inflammation and FibrosisSeminars in Liver Disease, 2010
- Macrophages, Inflammation, and Insulin ResistanceAnnual Review of Physiology, 2010
- Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis‐promoted hepatocarcinogenesis in ratsInternational Journal of Cancer, 2009
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin ResistanceCell Metabolism, 2008
- Erythrophagocytosis by Liver Macrophages (Kupffer Cells) Promotes Oxidative Stress, Inflammation, and Fibrosis in a Rabbit Model of SteatohepatitisThe American Journal of Pathology, 2007
- Inflammation and metabolic disordersNature, 2006
- Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2Journal of Hepatology, 2006